The Effects of Different Extracts of Viola Odorata on Trichomonas Vaginalis in Culture Medium

Document Type : Original Article (s)

Authors

1 Student of Pharmacy, School of Pharmacy and Pharmaceutical Sciences AND Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran

2 Professor Department of Pharmacognosy, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

3 Instructor, Department of Mycology and Parasitology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

4 Professor, Infectious Diseases and Tropical Medicine Research Center AND Department of Mycology and Parasitology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Tichomoniasis is a very common sexually transmitted disease (STD) caused by Trichomonas vaginalis. Metronidazol with vast side effects is now the only drug approved for the treatment of this infection in many countries. The effect of Viola odorata on several parasites is shown in previous studies. In this study, in an attempt to find an alternative drug, the effect of different extracts of this plant on Trichomonas vaginalis in culture medium was investigated.Methods: Three different fractions of leave, flower, and root including diethyl ether, ethyl acetate, and water fractions were prepared from crude extract. The extracts were dried using vacuum rotary evaporator and then, they were used for in-vitro anti-trichomonas vaginalis experiments.Findings: The crude extract of leave (4 mg/ml), flower (4 mg/ml), and root (2 mg/ml) of Viola odorata showed 100% growth inhibition (GI) during 24 hours. Diethyl ether fraction of leave, flower, and root of Viola odorata in concentration of 6 mg/ml showed 100% growth inhibition during 24 hours. The ethyl acetate fraction of leave, flower, and root revealed 100% growth inhibition in the first 24 hours with the minimum concentration of 20 mg/ml, 25 mg/ml, and 25 mg/ml, respectively. Water fraction of leave, flower, and root showed 100% growth inhibition during 24 hours in concentrations of 5, 3, and 1.5 mg/ml, respectively.Conclusion: Considering the appropriate effect of Viola odorata on Trichomonas vaginalis, more investigation is recommended to convert this plant to an anti-Trichomonas vaginalis drug.

Keywords

References

  1. Nanda N, Michel RG, Kurdgelashvili G, Wendel KA. Trichomoniasis and its treatment. Expert Rev Anti Infect Ther 2006; 4(1): 125-35.
  2. Swygard H, Sena AC, Hobbs MM, Cohen MS. Trichomoniasis: clinical manifestations, diagnosis and management. Sex Transm Infect 2004; 80(2): 91-5.
  3. Petrin D, Delgaty K, Bhatt R, Garber G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 1998; 11(2): 300-17.
  4. Garber GE. The laboratory diagnosis of Trichomonas vaginalis. Can J Infect Dis Med Microbiol 2005; 16(1): 35-8.
  5. Schwebke JR, Burgess D. Trichomoniasis. Clin Microbiol Rev 2004; 17(4): 794-803, table.
  6. Centers for Disease Control and Preventio. Trichomoniasis-CDC fact sheet [Online]. [cited 2007]; Available from: URL: http://www.cdc.gov/std/trichomonas/stdfact-trichomoniasis.htm/
  7. Stark JR, Judson G, Alderete JF, Mundodi V, Kucknoor AS, Giovannucci EL, et al. Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study. J Natl Cancer Inst 2009; 101(20): 1406-11.
  8. Edwards DI. Nitroimidazole drugs-action and resistance mechanisms. I. Mechanisms of action. J Antimicrob Chemother 1993; 31(1): 9-20.
  9. Grossman JH, Galask RP. Persistent vaginitis caused by metronidazole-resistant trichomonas. Obstet Gynecol 1990; 76(3 Pt 2): 521-2.
  10. Kurohara ML, Kwong FK, Lebherz TB, Klaustermeyer WB. Metronidazole hypersensitivity and oral desensitization. J Allergy Clin Immunol 1991; 88(2): 279-80.
  11. Asakawa B, Asakawa S. California Gardener's Guide. Brentwood, TN: Cool Springs Press; 2001.
  12. Ireland DC, Colgrave ML, Craik DJ. A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability. Biochem J 2006; 400(1): 1-12.
  13. Karioti A, Furlan C, Vincieri FF, Bilia AR. Analysis of the constituents and quality control of Viola odorata aqueous preparations by HPLC-DAD and HPLC-ESI-MS. Anal Bioanal Chem 2011; 399(4): 1715-23.
  14. British Herbal Medicine Association, Bradley PR. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs. London, UK: British Herbal Medicine Association; 2006. p. 381-4.
  15. Hartwell JL. Plants Used Against Cancer: A Survey. Lincoln, MA: Quarterman Publication; 1982. p. 438-9.
  16. Duke JA. Handbook of Medicinal Herbs. Boca Raton, FL: CRC Press; 1985. p. 457
  17. Lewis WH, Elvin-Lewis PF. Medical Botany: Plants Affecting Man's Health. New Jersey, NJ: John Wiley & Sons; 1977. p. 389-90.
  18. Pranting M, Loov C, Burman R, Goransson U, Andersson DI. The cyclotide cycloviolacin O2 from Viola odorata has potent bactericidal activity against Gram-negative bacteria. J Antimicrob Chemother 2010; 65(9): 1964-71.
  19. Amin Gh, Salehi MH, Yasa N, Aynehchi Y, Dehmoobed A, Emami M, et al. Screening of Iranian plants for antifungal activity: Part 2. DARU Journal of Pharmaceutical Sciences 2002; 10(2): 78-89.
  20. Verma AR, Vijayakumar M, Mathela CS, Rao CV. In vitro and in vivo antioxidant properties of different fractions of Moringa oleifera leaves. Food and Chemical Toxicology 2009; 47(9): 2196-201.
  21. Moon T, Wilkinson JM, Cavanagh HM. Antiparasitic activity of two Lavandula essential oils against Giardia duodenalis, Trichomonas vaginalis and Hexamita inflata. Parasitol Res 2006; 99(6): 722-8.
  22. Tonkal A. In Vitro Antitrichomonal Effect of Nigella Sativa Aqueous Extract and Wheat Germ Agglutinin. JKAU: Med Sci 2009; 16: 17-34.
  23. Thongyoo P, Tate EW, Leatherbarrow RJ. Total synthesis of the macrocyclic cysteine knot microprotein MCoTI-II. Chem Commun (Camb) 2006; (27): 2848-50.
  24. Khan A, Prakash R, Ali Sh, Aljarbou A, Khan MA. Comparative Study of Antibacterial Activity and Toxicity of Certain Plants used in Unani Medicine. Advances in Bioresearch 2011; 2(2): 10-3.
  25. Hammami I, Kamoun N, Rebai A. Biocontrol of Botrytis cinerea with essential oil and methanol extract of Viola odorata L. flowers. Archives of Applied Science Research 2011; 3(5): 44-51.
  26. Muhammad N, Saeed M, Awan AA, Khan H. Ethnomedicinal, phytochemical and pharmacological profile of genus Viola. Phytopharmacology 2012; 3(1): 214-26.
  27. Gerlach SL, Rathinakumar R, Chakravarty G, Goransson U, Wimley WC, Darwin SP, et al. Anticancer and chemosensitizing abilities of cycloviolacin 02 from Viola odorata and psyle cyclotides from Psychotria leptothyrsa. Biopolymers 2010; 94(5): 617-25.
  28. Zarrabi M, Dalirfardouei R, Sepehrizade Z, Kermanshahi RK. Comparison of the antimicrobial effects of semipurified cyclotides from Iranian Viola odorata against some of plant and human pathogenic bacteria. J Appl Microbiol 2013; 115(2): 367-75.
  29. Taran M, Rezaeian M, Izaddoost M. In vitro Antitrichomonas Activity of Allium Hirtifloium (Persian Shallot) in Comparison with Metronidazole. Iran J Public Health 2006; 35(1): 92-4.
  30. Soffar SA, Metwali DM, Abdel-Aziz SS, el-Wakil HS, Saad GA. Evaluation of the effect of a plant alkaloid (Berberine derived from Berberis aristata) on Trichomonas vaginalis in vitro. J Egypt Soc Parasitol 2001; 31(3): 893-904.
  31. Darani HY. Effects of different extracts of Eucalyptus camaldulensis on Trichomonas vaginalis parasite in culture medium. Advanced Biomedical Research 2013; 2(24): 1-4.
  32. Mahdi NK, Gany ZH, Sharief M. Alternative drugs against Trichomonas vaginalis. East Mediterr Health J 2006; 12(5): 679-84.
  33. LiLi Z, Yu C, YuanHua Q, YiXin R, Xin L, Lin T, et al. Effect of Mosla chinensis Maxim on Trichomonas vaginalis in vitro. Journal of DaliJournal of Dalian Medical Universityan Medical University 2009; 31(3): 282-5.
  34. Ertabaklar H, Kivcak B, Mert T, Ozensoy TS. In vitro activity of Arbutus unedo leaf extracts against Trichomonas vaginalis trophozoites. Turkiye Parazitol Derg 2009; 33(4): 263-5.
  35. Yousofi Darani H, Sereshti M, Zebardast N, Rafean M, Manochehre Naeini K, Yousofi Y. Effect of Ethanolic and Watery Extract of Aerial Parts of Stachys Lavandulifolia on Trichomonas vaginalis, In vitro. Journal of Medicinal Plants 2012; 11(8): 159-65.
  36. Arefkhah N, Taghipur S, Yousefi M, Rafeiean M, Daneshpur Sh, Yousefi H. In-Vitro Effect of Hydro-Alcoholic Extract of Tanacetum Parthenium Extract on Trichomonas Vaginalis. J Isfahan Med Sch 2013; 31(236): 623-9. [In Persian].
  37. Youse HA, Kazemian A, Sereshti M, Rahmanikhoh E, Ahmadinia E, Rafaian M, et al. Effect of Echinophora platyloba, Stachys lavandulifolia, and Eucalyptus camaldulensis plants on Trichomonas vaginalis growth in vitro. Adv Biomed Res 2012; 1: 79.
  38. Yousefi M, Taghipur S, Arefkhah N, Rahimian R, Davoudian A, Rafeiean M, et al. In-Vitro Effect of Menthe Piperita and Salvia Officinalis Extracts on Trichomonas Vaginalis. J Isfahan Med Sch 2013; 31(240): 811-8. [In Persian].
Journal of Isfahan Medical School
Volume 31, Issue 266 - Serial Number 266
November and December 2014
Pages 2139-2148

Files

History

  • Receive Date: 18 October 2013
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics